APVARDI
Live / Applied — Fourth extension granted (statement of use) (as of 25 Jul 2025)
What this means for you
Not registered yet, but its 22 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97515683
- Mark type
- Stylized text
- Filed
- 22 Jul 2022
- Published for opposition
- 13 Jun 2023
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological, nephrological, autoimmune, immunological, ocular, neurological and inflammatory related diseases and disorders
Owner
- Alexion Pharmaceuticals, Inc., Boston, MA, US
- Alexion Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 21 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jul 2025 — SOU EXTENSION 4 GRANTED
- 25 Jul 2025 — SOU EXTENSION 4 FILED
- 25 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jan 2025 — SOU EXTENSION 3 GRANTED
- 28 Jan 2025 — SOU EXTENSION 3 FILED
- 28 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2024 — SOU EXTENSION 2 GRANTED
- 16 Jul 2024 — SOU EXTENSION 2 FILED
- 16 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 24 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 May 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED